PRQR - צמיחת מכירות משנה לשנה (TTM) proqr.com

The GURU.Markets interface displays this trailing annual revenue growth chart, where the 19.60 mark records this metric for ProQR Therapeutics N.V. (PRQR). This trend reflects an autonomous cycle of medical innovation that remains independent of macroeconomic factors. Capital is secured by advances from pharma behemoths for the Axiomer platform, while the reliability of clinic deliveries is guaranteed by strict adherence to the cold chain during drug transportation.
ProQR Therapeutics - פילוחים אנליטיים ומדדי מפתח (PRQR)

This metric is calculated as the percentage change in total revenue over the last twelve months relative to the same period last year, measuring the actual speed of business expansion without market noise. For ProQR Therapeutics N.V. (PRQR) on GURU.Markets, the TTM revenue growth rate relative to last year reveals the resilience of operations to geopolitical risks and export restrictions on the cross-border transfer of medical technologies.